PUBLISHER: Grand View Research | PRODUCT CODE: 1751302
PUBLISHER: Grand View Research | PRODUCT CODE: 1751302
U.S. breath analyzers market size is expected to reach USD 3.13 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 15.64% from 2025 to 2030. Growing demand for breath analyzers from law enforcement agencies and other institutions such as schools, sports, and offices to minimize alcohol abuse is a major market driver. Early diagnosis of diseases such as cancer, tuberculosis, and Chronic Obstructive Pulmonary Disease (COPD) plays a key role in the success rate of their treatment. Breath analyzers offer a quick primary diagnosis based on exhaled air contents.
Growing applications in private use such as measurement of breath Carbon Monoxide (CO) in smoking cessation activities are expected to boost market growth during the forecast period. During the COVID-19 pandemic, the breathalyzer market experienced a downturn as most commercial activities were halted. Owing to a close in production units and an interruption in the supply chain, most main revenue-generating end-users of the market were impacted, resulting reduction in sales of breath analyzers. However, the COVID-19 pandemic brought about a series of changes across industries.
For instance, the U.S. Department of Transportation announced that in the future new cars will be equipped with alcohol-sensing start buttons, which will prevent them from moving if it detects alcohol. Hence, it is expected that the market will witness the introduction of novel, innovative technologies, and new product launches during the forecast period, in turn, positively impacting growth. The growing prevalence of noncommunicable illnesses, along with the high rate of infectious diseases, is driving the double disease burden across the world. Hence, there is a significant demand for cheap, accessible, and ruggedized diagnostic tools that detect diseases early and direct patients to the right treatment channels.
Furthermore, the growing number of road accidents due to drunk driving and drug abuse has augmented the demand for breath analyzers, as these devices help monitor the presence of different compounds and measure the blood alcohol content in a breath sample. Sometimes breath analyzers provide inaccurate results, failing to differentiate alcohol from any other chemical compound that holds a methyl group structure. Some alcohol testing machines recognize not only ethyl alcohol but also any compound with a similar molecular structure. Thus, accuracy concerns pertaining to breath analyzers are expected to limit market growth.